Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03038178
Recruitment Status : Active, not recruiting
First Posted : January 31, 2017
Last Update Posted : August 27, 2019
Sponsor:
Collaborators:
Insmed Incorporated
The University of Texas Health Science Center at Tyler
Information provided by (Responsible Party):
Kevin Winthrop, Oregon Health and Science University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : December 2019